Mirasol Pathogen Reduction Technology System
Device
Terumo BCT, Inc.
Total Payments
$7.8M
Transactions
650
Doctors
22
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $386,435 | 18 | 3 |
| 2020 | $2.2M | 205 | 5 |
| 2019 | $2.6M | 203 | 17 |
| 2018 | $2.7M | 224 | 14 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $6.8M | 249 | 86.7% |
| Consulting Fee | $954,747 | 171 | 12.2% |
| Travel and Lodging | $84,423 | 114 | 1.1% |
| Food and Beverage | $4,477 | 116 | 0.1% |
Payments by Type
Research
$6.8M
249 transactions
General
$1.0M
401 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CTS-5030 MIPLATE | Terumo BCT, Inc. | $4.3M | 1 |
| CTS-5030 Miplate | Terumo BCT, Inc. | $1.5M | 0 |
| CTS-5030 - Miplate | Terumo BCT, Inc. | $572,324 | 0 |
| CTS 5056 PRAISE | Terumo BCT, Inc. | $294,706 | 0 |
| CTS-5056 PRAISE | Terumo BCT, Inc. | $111,842 | 0 |
| Effects of UV Exposure during Mirasol Treatment on Red Blood Cells | Terumo BCT, Inc. | $20,142 | 0 |
Top Doctors Receiving Payments for Mirasol Pathogen Reduction Technology System
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Omaha, NE | $6.8M | 246 |
| , MD | Blood Banking & Transfusion Medicine | Minneapolis, MN | $312,297 | 165 |
| , MD | Pediatric Nephrology | Cleveland, OH | $304,926 | 48 |
| , M.D | Internal Medicine | Baltimore, MD | $210,623 | 107 |
| , MD | Family Medicine | Napa, CA | $180,237 | 31 |
| , M.D | Anesthesiology | San Francisco, CA | $13,876 | 6 |
| , M.D | Infectious Disease | Davenport, IA | $8,748 | 11 |
| , M.D | Pediatrics | Oakland, CA | $4,412 | 3 |
| , MD | Pediatric Hematology-Oncology | Dallas, TX | $3,383 | 6 |
| Sherrill Slichter | — | Seattle, WA | $2,178 | 6 |
| , MD | Hematology & Oncology | Aurora, CO | $1,950 | 2 |
| , M.D., PH.D | Blood Banking & Transfusion Medicine | Baltimore, MD | $1,433 | 8 |
| , MD | Infectious Disease | Aurora, CO | $1,400 | 1 |
| , MD | Blood Banking & Transfusion Medicine | Washington, DC | $62.10 | 1 |
| , M.D | Blood Banking & Transfusion Medicine | Indianapolis, IN | $62.10 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | Lauderhill, FL | $62.10 | 1 |
| , M.D | Blood Banking & Transfusion Medicine | Houston, TX | $62.10 | 1 |
| , M.D | Blood Banking & Transfusion Medicine | Jacksonville, FL | $62.10 | 1 |
| , M.D | Anatomic Pathology & Clinical Pathology | Denver, CO | $62.10 | 1 |
| , MD, PHD | Blood Banking & Transfusion Medicine | San Francisco, CA | $62.10 | 1 |
| , MD, PHD | Anatomic Pathology & Clinical Pathology | Nashville, TN | $56.33 | 1 |
| , DO | Clinical Pathology | Salt Lake City, UT | $56.33 | 1 |
| , M.D | Hematology | Potomac, MD | $17.35 | 1 |
Ad
Manufacturing Companies
- Terumo BCT, Inc. $7.8M
Product Information
- Type Device
- Total Payments $7.8M
- Total Doctors 22
- Transactions 650
About Mirasol Pathogen Reduction Technology System
Mirasol Pathogen Reduction Technology System is a device associated with $7.8M in payments to 22 healthcare providers, recorded across 650 transactions in the CMS Open Payments database. The primary manufacturer is Terumo BCT, Inc..
Payment data is available from 2018 to 2021. In 2021, $386,435 was paid across 18 transactions to 3 doctors.
The most common payment nature for Mirasol Pathogen Reduction Technology System is "Unspecified" ($6.8M, 86.7% of total).
Mirasol Pathogen Reduction Technology System is associated with 6 research studies, including "CTS-5030 MIPLATE" ($4.3M).